Kaitlyn Bader, Associate Editor

MW005 treatment for low-risk basal cell carcinoma would offer patients an alternative to surgical excision.

Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.

This week's edition of the Mainstream Patient features stories about night creams, skincare routines, beauty sales, and more.

An early-stage clinical trial will evaluate an investigational vaccine to prevent Nipah virus infection.

ICYMI, this week we had stories about atopic dermatitis, acne, psoriasis, consumer trends, and more.

The groundbreaking approval of sirolimus topical gel brings relief to patients with facial angiofibroma related to tuberous sclerosis complex with the first FDA-approved topical treatment.

Perimenopausal, menopausal, and postmenopausal women experienced a progressive improvement in hair growth, shedding, quality of life, and menopausal symptoms after 12 months with an active nutraceutical supplement.

In this episode, Raj Chovatiya, MD, PhD, and assistant professor of dermatology and director of the Center for Ecezma and Itch at the Northwestern University Feinberg School of Medicine, discusses the changing field of atopic dermatitis, the importance of JAK inhibitors, and the treatment options he looks forward to.

This week's edition of the Mainstream Patient features stories about dermaplaning tools, pregnancy-safe sunscreens, botox, and more.

ICYMI, this week we had stories about the Society for Pediatric Dermatology 2022 Meeting, FDA updates, mental health, and more.

Cynthia J. Trickett, PA-C, MPAS, discusses the personal and clinical effects of atopic dermatitis in adult and pediatric patients at the Maui Derm NP+PA 2022 Summer Conference in Colorado Springs, Colorado.

Verrica is complying with the FDA through 3 Complete Response Letters to achieve the first FDA-approved treatment of molluscum contagiosum.

This week's edition of the Mainstream Patient features stories about abortions, spray sunscreen, tinted moisturizers, and more.

Kenneth Gordon, MD, professor and chair of dermatology at the Medical College of Wisconsin, discusses new topical therapy treatment options for psoriasis and what he's looking forward to.

Melodie Young, MSN, A/GNP-C, nurse practitioner at Mindful Dermatology and a partner and sub-investigator with Modern Research Associates in Dallas, Texas, explains what NPs and PAs can bring to the dermatology space.

ICYMI, this week we had stories about pediatric atopic dermatitis, managing complex diseases, Medicare, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of June.

Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine, discusses new treatments and therapies for pediatric atopic dermatitis.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the treatments for psoriatic arthritis, the comorbidities that have to be considered, and more.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the future of psoriatic arthritis.

James Treat, MD, dives into pediatric patients dealing with alopecia areata, sleep issues in children with atopic dermatitis, and more.

Maui Derm NP+PA Summer 2022 Conference begins today in Colorado Springs, Colorado, offering a selection of in-person and virtual educational workshops and presentations.

The 2022 National Infusion Center Association Conference will begin with several sessions focused on advocacy, clinical, management, and operations topics.

First clinical results for the treatment of central centrifugal cicatricial alopecia in Black women introduce more inclusive solutions.

New Renuvion Dermal Handpiece is approved to effectively treat more dermal appearances such as wrinkles and rhytides.